Human medicines European public assessment report (EPAR): Capecitabine Teva, capecitabine, Colonic Neoplasms,Breast Neoplasms,Colorectal Neoplasms,Stomach Neoplasms, Date of authorisation: 20/04/2012, Revision: 10, Status: Authorised
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.